{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:29:44Z","timestamp":1792600184010,"version":"4.5.0"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite extensive research, open questions about the biological underpinnings of Alzheimer\u2019s disease (AD) remain. Neuroimaging biomarkers based on positron emission tomography (PET) and magnetic resonance imaging (MRI) offer in vivo insights into these complex biological changes and interactions. However, most evidence to date comes from cross-sectional studies, limiting our understanding of disease progression. Longitudinal studies enable the investigation of biological changes within individuals, revealing how pathology evolves over time. With this review, we provide an overview of how longitudinal imaging biomarker studies have advanced the field and how they can contribute to future research. We highlight longitudinal biomarker studies that have provided critical insights into disease trajectories, staging, and individual variability. We further assess longitudinal multimodal studies which have elucidated interactions between AD-specific pathology, amyloid-\u03b2 and tau, and broader biological changes like neurodegeneration, neuronal dysfunction, vascular disease, and inflammation. Further, we discuss associations of brain changes with symptomatology and clinical outcomes and conclude with challenges and future directions.<\/jats:p>","DOI":"10.1186\/s13195-025-01920-6","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:05:15Z","timestamp":1764817515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Longitudinal biomarker studies in human neuroimaging: capturing biological change of Alzheimer\u2019s pathology"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9936-2954","authenticated-orcid":false,"given":"Larissa","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-412X","authenticated-orcid":false,"given":"Dana","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-775X","authenticated-orcid":false,"given":"Samira","family":"Maboudian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4156-1037","authenticated-orcid":false,"given":"Corrina","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8448-8678","authenticated-orcid":false,"given":"Claudia","family":"Tato-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Annen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0798-6250","authenticated-orcid":false,"given":"Prithvi","family":"Arunachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7408-0984","authenticated-orcid":false,"given":"Julia R.","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0779-1592","authenticated-orcid":false,"given":"Michelle","family":"Barboure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8450-3806","authenticated-orcid":false,"given":"Serena","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2505-770X","authenticated-orcid":false,"given":"Stamatia","family":"Karagianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6263-1762","authenticated-orcid":false,"given":"Lyduine E.","family":"Collij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Edison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-657X","authenticated-orcid":false,"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9736-2283","authenticated-orcid":false,"given":"Nicolai","family":"Franzmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-9022","authenticated-orcid":false,"given":"Michel J.","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4458-113X","authenticated-orcid":false,"given":"William J.","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7889-795X","authenticated-orcid":false,"given":"Anne","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8923-9656","authenticated-orcid":false,"given":"Maura","family":"Malpetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9372-3635","authenticated-orcid":false,"given":"Ross W.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7869-8192","authenticated-orcid":false,"given":"Aitana","family":"Sogorb-Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7800-1781","authenticated-orcid":false,"given":"Michael","family":"Sch\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"1920_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89\u201395.","journal-title":"Clin Pharmacol Ther"},{"key":"1920_CR2","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association workgroup. Alzheimer\u2019s & Dementia. 2024;20:5143\u201369.","journal-title":"Alzheimer's & Dementia"},{"key":"1920_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0325-5","volume":"14","author":"F M\u00e1rquez","year":"2019","unstructured":"M\u00e1rquez F, Yassa MA. Neuroimaging biomarkers for Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:21.","journal-title":"Mol Neurodegener"},{"key":"1920_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"1920_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389\u2013404.","journal-title":"Acta Neuropathol"},{"key":"1920_CR6","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H. Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791\u2013800.","journal-title":"Neurology"},{"key":"1920_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8:595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"1920_CR8","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","volume":"89","author":"MJ Grothe","year":"2017","unstructured":"Grothe MJ, Barthel H, Sepulcre J, Dyrba M, Sabri O, Teipel SJ, et al. In vivo staging of regional amyloid deposition. Neurology. 2017;89:2031\u20138.","journal-title":"Neurology"},{"key":"1920_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.nicl.2013.02.006","volume":"2","author":"G Ch\u00e9telat","year":"2013","unstructured":"Ch\u00e9telat G, La Joie R, Villain N, Perrotin A, de La Sayette V, Eustache F, et al. Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer\u2019s disease. NeuroImage: Clinical. 2013;2:356\u201365.","journal-title":"NeuroImage: Clinical"},{"key":"1920_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00259-015-3208-1","volume":"43","author":"K Heurling","year":"2016","unstructured":"Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A. Imaging \u03b2-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis. Eur J Nucl Med Mol Imaging. 2016;43:362\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1920_CR11","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1093\/brain\/awz154","volume":"142","author":"A Maass","year":"2019","unstructured":"Maass A, Berron D, Harrison TM, Adams JN, La Joie R, Baker S, et al. Alzheimer\u2019s pathology targets distinct memory networks in the ageing brain. Brain. 2019;142:2492\u2013509.","journal-title":"Brain"},{"key":"1920_CR12","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00259-024-06603-2","volume":"51","author":"T G\u00e9rard","year":"2024","unstructured":"G\u00e9rard T, Colmant L, Malotaux V, Salman Y, Huyghe L, Quenon L, et al. The spatial extent of tauopathy on [F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2024;51:1662\u201374.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1920_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/archneur.63.5.693","volume":"63","author":"RA Dutton","year":"2006","unstructured":"Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol. 2006;63:693\u20139.","journal-title":"Arch Neurol"},{"key":"1920_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.nicl.2016.12.012","volume":"13","author":"CD Mayo","year":"2016","unstructured":"Mayo CD, Mazerolle EL, Ritchie L, Fisk JD, Gawryluk JR. Longitudinal changes in microstructural white matter metrics in Alzheimer\u2019s disease. NeuroImage Clinical. 2016;13:330\u20138.","journal-title":"NeuroImage Clinical"},{"issue":"11","key":"1920_CR15","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, et al. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol. 2020;19(11):951\u201362.","journal-title":"Lancet Neurol"},{"key":"1920_CR16","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1002\/alz.13720","volume":"20","author":"A Kumar","year":"2024","unstructured":"Kumar A, Scarpa M, Nordberg A. Tracing synaptic loss in Alzheimer\u2019s brain with SV2A PET-tracer UCB-J. Alzheimer\u2019s & Dementia. 2024;20:2589\u2013605.","journal-title":"Alzheimer's & Dementia"},{"key":"1920_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae376","volume":"6","author":"N Corriveau-Lecavalier","year":"2024","unstructured":"Corriveau-Lecavalier N, Adams JN, Fischer L, Molloy EN, Maass A. Cerebral hyperactivation across the Alzheimer\u2019s disease pathological cascade. Brain Commun. 2024;6:fcae376.","journal-title":"Brain Commun"},{"key":"1920_CR18","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1002\/mrm.29572","volume":"89","author":"T Lindner","year":"2023","unstructured":"Lindner T, Bolar DS, Achten E, Barkhof F, Bastos-Leite AJ, Detre JA, et al. Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging. Magn Reson Med. 2023;89:2024\u201347.","journal-title":"Magn Reson Med"},{"key":"1920_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jns.2012.07.032","volume":"322","author":"RN Kalaria","year":"2012","unstructured":"Kalaria RN, Akinyemi R, Ihara M. Does vascular pathology contribute to Alzheimer changes? J Neurol Sci. 2012;322:141\u20137.","journal-title":"J Neurol Sci"},{"key":"1920_CR20","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1002\/alz.13057","volume":"19","author":"A Garnier-Crussard","year":"2023","unstructured":"Garnier-Crussard A, Cotton F, Krolak-Salmon P, Ch\u00e9telat G. White matter hyperintensities in Alzheimer\u2019s disease: beyond vascular contribution. Alzheimer\u2019s & Dementia. 2023;19:3738\u201348.","journal-title":"Alzheimer's & Dementia"},{"key":"1920_CR21","doi-asserted-by":"publisher","first-page":"e2192","DOI":"10.1212\/WNL.0000000000011783","volume":"96","author":"D Kerkhofs","year":"2021","unstructured":"Kerkhofs D, Wong SM, Zhang E, Staals J, Jansen JFA, van Oostenbrugge RJ, et al. Baseline blood-brain barrier leakage and longitudinal microstructural tissue damage in the periphery of white matter hyperintensities. Neurology. 2021;96:e2192.","journal-title":"Neurology"},{"key":"1920_CR22","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1038\/s41467-023-40937-z","volume":"14","author":"E Nutma","year":"2023","unstructured":"Nutma E, Fancy N, Weinert M, Tsartsalis S, Marzin MC, Muirhead RCJ, et al. Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases. Nat Commun. 2023;14:5247.","journal-title":"Nat Commun"},{"key":"1920_CR23","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/brain\/awaf078","volume":"148","author":"SS Wijesinghe","year":"2025","unstructured":"Wijesinghe SS, Rowe JB, Mason HD, Allinson KSJ, Thomas R, Vontobel DS, et al. Post-mortem validation of in vivo TSPO PET as a microglial biomarker. Brain. 2025;148:1904\u201310. https:\/\/doi.org\/10.1093\/brain\/awaf078.","journal-title":"Brain"},{"key":"1920_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-023-00647-y","volume":"18","author":"K Chiotis","year":"2023","unstructured":"Chiotis K, Johansson C, Rodriguez-Vieitez E, Ashton NJ, Blennow K, Zetterberg H, et al. Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer\u2019s disease with multi-modal PET and plasma GFAP. Mol Neurodegener. 2023;18:1\u201314.","journal-title":"Mol Neurodegener"},{"key":"1920_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00401-018-1897-9","volume":"136","author":"DR Thal","year":"2018","unstructured":"Thal DR, Beach TG, Zanette M, Lilja J, Heurling K, Chakrabarty A, et al. Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid \u03b2-protein deposition. Acta Neuropathol. 2018;136:557\u201367.","journal-title":"Acta Neuropathol"},{"key":"1920_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2967\/jnumed.119.235879","volume":"61","author":"E Fantoni","year":"2020","unstructured":"Fantoni E, Collij L, Alves IL, Buckley C, Farrar G. The spatial-temporal ordering of amyloid pathology and opportunities for PET imaging. J Nucl Med. 2020;61:166\u201371.","journal-title":"J Nucl Med"},{"key":"1920_CR27","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jamaneurol.2019.2214","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Palmqvist S, Stomrud E, Vogel J, Hansson O. Staging \u03b2-amyloid pathology with amyloid positron emission tomography. JAMA Neurol. 2019;76:1319\u201329.","journal-title":"JAMA Neurol"},{"key":"1920_CR28","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1002\/hbm.25121","volume":"41","author":"I Jelistratova","year":"2020","unstructured":"Jelistratova I, Teipel SJ, Grothe MJ. Longitudinal validity of PET-based staging of regional amyloid deposition. Hum Brain Mapp. 2020;41:4219\u201331.","journal-title":"Hum Brain Mapp"},{"key":"1920_CR29","doi-asserted-by":"publisher","first-page":"e1538","DOI":"10.1212\/WNL.0000000000010256","volume":"95","author":"LE Collij","year":"2020","unstructured":"Collij LE, Heeman F, Salvad\u00f3 G, Ingala S, Altomare D, de Wilde A, et al. Multitracer model for staging cortical amyloid deposition using PET imaging. Neurology. 2020;95:e1538\u201353.","journal-title":"Neurology"},{"key":"1920_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2019;76:791\u20139.","journal-title":"JAMA Neurol"},{"key":"1920_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2022.03.005","volume":"115","author":"MR LaPoint","year":"2022","unstructured":"LaPoint MR, Baker SL, Landau SM, Harrison TM, Jagust WJ. Rates of \u03b2-amyloid deposition indicate widespread simultaneous accumulation throughout the brain. Neurobiol Aging. 2022;115:1\u201311.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1920_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207\u201316.","journal-title":"Lancet Neurol"},{"key":"1920_CR33","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/brain\/aws125","volume":"135","author":"N Villain","year":"2012","unstructured":"Villain N, Ch\u00e9telat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, et al. Regional dynamics of amyloid-\u03b2 deposition in healthy elderly, mild cognitive impairment and Alzheimer\u2019s disease: a voxelwise PiB-PET longitudinal study. Brain. 2012;135:2126\u201339.","journal-title":"Brain"},{"key":"1920_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5281829","volume":"2017","author":"A Pignataro","year":"2017","unstructured":"Pignataro A, Middei S. Trans-synaptic spread of amyloid-\u03b2 in Alzheimer\u2019s disease: paths to \u03b2-amyloidosis. Neural Plast. 2017;2017:5281829.","journal-title":"Neural Plast"},{"key":"1920_CR35","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38:1205\u201335.","journal-title":"Acta Pharmacol Sin"},{"key":"1920_CR36","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76:915\u201324.","journal-title":"JAMA Neurol"},{"key":"1920_CR37","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/brain\/awaa276","volume":"143","author":"DN Soleimani-Meigooni","year":"2020","unstructured":"Soleimani-Meigooni DN, Iaccarino L, La Joie R, Baker S, Bourakova V, Boxer AL, et al. 18F-flortaucipir PET to autopsy comparisons in Alzheimer\u2019s disease and other neurodegenerative diseases. Brain. 2020;143:3477\u201394.","journal-title":"Brain"},{"key":"1920_CR38","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, et al. Pet imaging of tau deposition in the aging human brain. Neuron. 2016;89:971\u201382.","journal-title":"Neuron"},{"key":"1920_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae031","volume":"6","author":"F St-Onge","year":"2024","unstructured":"St-Onge F, Chapleau M, Breitner JCS, Villeneuve S, Pichet Binette A. Tau accumulation and its spatial progression across the Alzheimer\u2019s disease spectrum. Brain Commun. 2024;6:fcae031.","journal-title":"Brain Commun"},{"key":"1920_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adp2564","volume":"17","author":"SN Roemer-Cassiano","year":"2025","unstructured":"Roemer-Cassiano SN, Wagner F, Evangelista L, Rauchmann BS, Dehsarvi A, Steward A, et al. Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer\u2019s disease. Sci Transl Med. 2025;17:eadp2564.","journal-title":"Sci Transl Med"},{"key":"1920_CR41","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1038\/s41467-022-32592-7","volume":"13","author":"L Frontzkowski","year":"2022","unstructured":"Frontzkowski L, Ewers M, Brendel M, Biel D, Ossenkoppele R, Hager P, et al. Earlier Alzheimer\u2019s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading. Nat Commun. 2022;13:4899.","journal-title":"Nat Commun"},{"key":"1920_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd1327","volume":"6","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier N, Dewenter A, Frontzkowski L, Dichgans M, Rubinski A, Neitzel J, et al. Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer\u2019s disease. Sci Adv. 2020;6:eabd1327.","journal-title":"Sci Adv"},{"key":"1920_CR43","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel JW, Young AL, Oxtoby NP, Smith R, Ossenkoppele R, Strandberg OT, et al. Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease. Nat Med. 2021;27:871\u201381.","journal-title":"Nat Med"},{"key":"1920_CR44","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamaneurol.2023.1067","volume":"80","author":"A Leuzy","year":"2023","unstructured":"Leuzy A, Binette AP, Vogel JW, Klein G, Borroni E, Tonietto M, et al. Comparison of group-level and individualized brain regions for measuring change in longitudinal tau positron emission tomography in Alzheimer disease. JAMA Neurol. 2023;80:614\u201323.","journal-title":"JAMA Neurol"},{"key":"1920_CR45","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1002\/alz.13164","volume":"19","author":"D Tosun","year":"2023","unstructured":"Tosun D, Thropp P, Southekal S, Spottiswoode B, Fahmi R. Profiling and predicting distinct tau progression patterns: an unsupervised data-driven approach to flortaucipir positron emission tomography. Alzheimer\u2019s & Dementia. 2023;19:5605\u201319.","journal-title":"Alzheimer's & Dementia"},{"key":"1920_CR46","doi-asserted-by":"publisher","first-page":"118126","DOI":"10.1016\/j.neuroimage.2021.118126","volume":"237","author":"F Yang","year":"2021","unstructured":"Yang F, Chowdhury SR, Jacobs HIL, Sepulcre J, Wedeen VJ, Johnson KA, et al. Longitudinal predictive modeling of tau progression along the structural connectome. Neuroimage. 2021;237:118126.","journal-title":"Neuroimage"},{"key":"1920_CR47","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1523\/JNEUROSCI.1601-21.2021","volume":"42","author":"JN Adams","year":"2022","unstructured":"Adams JN, Harrison TM, Maass A, Baker SL, Jagust WJ. Distinct factors drive the spatiotemporal progression of tau pathology in older adults. J Neurosci. 2022;42:1352\u201361.","journal-title":"J Neurosci"},{"issue":"5","key":"1920_CR48","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/brain\/awy059","volume":"141","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, et al. Longitudinal tau PET in ageing and Alzheimer\u2019s disease. Brain. 2018;141(5):1517\u201328.","journal-title":"Brain"},{"key":"1920_CR49","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2967\/jnumed.118.221697","volume":"60","author":"H Cho","year":"2019","unstructured":"Cho H, Choi JY, Lee HS, Lee JH, Ryu YH, Lee MS, et al. Progressive tau accumulation in Alzheimer disease: 2-year follow-up study. J Nucl Med. 2019;60:1611\u201321.","journal-title":"J Nucl Med"},{"key":"1920_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6:67\u201377.","journal-title":"Nat Rev Neurol"},{"issue":"Pt 6","key":"1920_CR51","first-page":"2001","volume":"119","author":"NC Fox","year":"1996","unstructured":"Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, et al. Presymptomatic hippocampal atrophy in Alzheimer\u2019s disease. A longitudinal MRI study Brain. 1996;119(Pt 6):2001\u20137.","journal-title":"A longitudinal MRI study Brain"},{"key":"1920_CR52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/cercor\/bhn113","volume":"19","author":"BC Dickerson","year":"2009","unstructured":"Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, et al. The cortical signature of Alzheimer\u2019s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009;19:497\u2013510.","journal-title":"Cereb Cortex"},{"key":"1920_CR53","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1523\/JNEUROSCI.23-03-00994.2003","volume":"23","author":"PM Thompson","year":"2003","unstructured":"Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, et al. Dynamics of Gray Matter Loss in Alzheimer\u2019s Disease. J Neurosci. 2003;23:994\u20131005.","journal-title":"J Neurosci"},{"key":"1920_CR54","doi-asserted-by":"publisher","first-page":"15223","DOI":"10.1523\/JNEUROSCI.3252-09.2009","volume":"29","author":"AM Fjell","year":"2009","unstructured":"Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, et al. One-year brain atrophy evident in healthy aging. J Neurosci. 2009;29:15223\u201331.","journal-title":"J Neurosci"},{"key":"1920_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5732","volume":"12","author":"R La Joie","year":"2020","unstructured":"La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12:eaau5732.","journal-title":"Sci Transl Med"},{"key":"1920_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.10424","volume":"53","author":"JM Schott","year":"2003","unstructured":"Schott JM, Fox NC, Frost C, Scahill RI, Janssen JC, Chan D, et al. Assessing the onset of structural change in familial Alzheimer\u2019s disease. Ann Neurol. 2003;53:181\u20138.","journal-title":"Ann Neurol"},{"key":"1920_CR57","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.neurobiolaging.2009.11.013","volume":"32","author":"WD Knight","year":"2011","unstructured":"Knight WD, Kim LG, Douiri A, Frost C, Rossor MN, Fox NC. Acceleration of cortical thinning in familial Alzheimer\u2019s disease. Neurobiol Aging. 2011;32:1765\u201373.","journal-title":"Neurobiol Aging"},{"key":"1920_CR58","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1007\/s00330-009-1512-5","volume":"19","author":"JD Sluimer","year":"2009","unstructured":"Sluimer JD, van der Flier WM, Karas GB, van Schijndel R, Barnes J, Boyes RG, et al. Accelerating regional atrophy rates in the progression from normal aging to Alzheimer\u2019s disease. Eur Radiol. 2009;19:2826\u201333.","journal-title":"Eur Radiol"},{"key":"1920_CR59","doi-asserted-by":"publisher","first-page":"e2533","DOI":"10.1212\/WNL.0000000000207962","volume":"101","author":"BJ Hanseeuw","year":"2023","unstructured":"Hanseeuw BJ, Jacobs HIL, Schultz AP, Buckley RF, Farrell ME, Guehl NJ, et al. Association of pathologic and volumetric biomarker changes with cognitive decline in clinically normal adults. Neurology. 2023;101:e2533-44.","journal-title":"Neurology"},{"key":"1920_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac134","volume":"4","author":"G Salvad\u00f3","year":"2022","unstructured":"Salvad\u00f3 G, Shekari M, Falcon C, Operto G, Mil\u00e0-Alom\u00e0 M, S\u00e1nchez-Benavides G, et al. Brain alterations in the early Alzheimer\u2019s continuum with amyloid-\u03b2, tau, glial and neurodegeneration CSF markers. Brain Commun. 2022;4:fcac134.","journal-title":"Brain Commun"},{"key":"1920_CR61","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S1474-4422(24)00335-1","volume":"23","author":"CRS Belder","year":"2024","unstructured":"Belder CRS, Boche D, Nicoll JAR, Jaunmuktane Z, Zetterberg H, Schott JM, et al. Brain volume change following anti-amyloid \u03b2 immunotherapy for Alzheimer\u2019s disease: amyloid-removal-related pseudo-atrophy. Lancet Neurol. 2024;23:1025\u201334.","journal-title":"Lancet Neurol"},{"key":"1920_CR62","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1212\/WNL.0000000000207268","volume":"100","author":"F Barkhof","year":"2023","unstructured":"Barkhof F, Knopman DS. Brain shrinkage in anti-\u03b2-amyloid Alzheimer trials: neurodegeneration or pseudoatrophy? Neurology. 2023;100:941\u20132.","journal-title":"Neurology"},{"key":"1920_CR63","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/acn3.782","volume":"6","author":"L Iaccarino","year":"2019","unstructured":"Iaccarino L, Sala A, Perani D, Alzheimer\u2019s Disease Neuroimaging Initiative. Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET. Ann Clin Transl Neurol. 2019;6:1113\u201320.","journal-title":"Ann Clin Transl Neurol"},{"key":"1920_CR64","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","volume":"36","author":"L Mosconi","year":"2009","unstructured":"Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, et al. Fdg-pet changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2009;36:811\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1920_CR65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000278422","volume":"29","author":"SH Kim","year":"2010","unstructured":"Kim SH, Seo SW, Yoon DS, Chin J, Lee BH, Cheong H-K, et al. Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: a five-year longitudinal study. Dement Geriatr Cogn Disord. 2010;29:213\u201323.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1920_CR66","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.neurobiolaging.2014.04.006","volume":"35","author":"V Kljajevic","year":"2014","unstructured":"Kljajevic V, Grothe MJ, Ewers M, Teipel S. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer\u2019s disease. Neurobiol Aging. 2014;35:1973\u201381.","journal-title":"Neurobiol Aging"},{"key":"1920_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/alz.066508","volume":"18","author":"MJ Grothe","year":"2022","unstructured":"Grothe MJ, Silva-Rodr\u00edguez J, Moscoso A, Sch\u00f6ll M. FDG-PET is a sensitive imaging biomarker of the neurodegenerative changes that accompany early neurofibrillary tangle pathology. Alzheimers Dement. 2022;18:e066508.","journal-title":"Alzheimers Dement"},{"key":"1920_CR68","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study. Lancet Neurol. 2018;17:241\u201350.","journal-title":"Lancet Neurol"},{"key":"1920_CR69","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s00259-012-2102-3","volume":"39","author":"R Ossenkoppele","year":"2012","unstructured":"Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, et al. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET. Eur J Nucl Med Mol Imaging. 2012;39:990\u20131000.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1920_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0512-1","volume":"11","author":"Y-N Ou","year":"2019","unstructured":"Ou Y-N, Xu W, Li J-Q, Guo Y, Cui M, Chen K-L, et al. FDG-PET as an independent biomarker for Alzheimer\u2019s biological diagnosis: a longitudinal study. Alzheimers Res Ther. 2019;11:57.","journal-title":"Alzheimers Res Ther"},{"key":"1920_CR71","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neuroimage.2011.12.071","volume":"60","author":"KR Gray","year":"2012","unstructured":"Gray KR, Wolz R, Heckemann RA, Aljabar P, Hammers A, Rueckert D. Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer\u2019s disease. Neuroimage. 2012;60:221\u20139.","journal-title":"Neuroimage"},{"key":"1920_CR72","doi-asserted-by":"crossref","unstructured":"Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA. 2001;286:2120\u20137.","DOI":"10.1001\/jama.286.17.2120"},{"key":"1920_CR73","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/alz.12763","volume":"19","author":"MJ Grothe","year":"2023","unstructured":"Grothe MJ, Moscoso A, Silva-Rodr\u00edguez J, Lange C, Nho K, Saykin AJ, et al. Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC. Alzheimers Dement. 2023;19:1234\u201344.","journal-title":"Alzheimers Dement"},{"key":"1920_CR74","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2967\/jnumed.122.264213","volume":"64","author":"J Silva-Rodr\u00edguez","year":"2023","unstructured":"Silva-Rodr\u00edguez J, Labrador-Espinosa MA, Moscoso A, Sch\u00f6ll M, Mir P, Grothe MJ. Differential effects of tau stage, Lewy body pathology, and substantia nigra degeneration on 18F-FDG PET patterns in clinical Alzheimer disease. J Nucl Med. 2023;64:274\u201380.","journal-title":"J Nucl Med"},{"key":"1920_CR75","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/s41380-024-02501-z","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang J, Huang Q, Chen X, You Z, He K, Guo Q, et al. Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer\u2019s disease. Mol Psychiatry. 2024;29:2799\u2013809.","journal-title":"Mol Psychiatry"},{"key":"1920_CR76","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1038\/s41380-022-01672-x","volume":"27","author":"G Vanderlinden","year":"2022","unstructured":"Vanderlinden G, Ceccarini J, Vande CT, Michiels L, Lemmens R, Triau E, et al. Spatial decrease of synaptic density in amnestic mild cognitive impairment follows the tau build-up pattern. Mol Psychiatry. 2022;27:4244\u201351.","journal-title":"Mol Psychiatry"},{"key":"1920_CR77","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jneumeth.2016.12.020","volume":"278","author":"F Kruggel","year":"2017","unstructured":"Kruggel F, Masaki F, Solodkin A, Alzheimer\u2019s Disease Neuroimaging Initiative. Analysis of longitudinal diffusion-weighted images in healthy and pathological aging: an ADNI study. J Neurosci Methods. 2017;278:101\u201315.","journal-title":"J Neurosci Methods"},{"key":"1920_CR78","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ana.410200406","volume":"20","author":"BT Hyman","year":"1986","unstructured":"Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer\u2019s disease. Ann Neurol. 1986;20:472\u201381.","journal-title":"Ann Neurol"},{"key":"1920_CR79","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF00868807","volume":"242","author":"P Scheltens","year":"1995","unstructured":"Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool WA. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol. 1995;242:557\u201360.","journal-title":"J Neurol"},{"key":"1920_CR80","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1002\/cne.23418","volume":"521","author":"A Solodkin","year":"2013","unstructured":"Solodkin A, Chen EE, Van Hoesen GW, Heimer L, Shereen A, Kruggel F, et al. In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer\u2019s disease: DTI Biomarkers for Alzheimer\u2019s Disease. J Comp Neurol. 2013;521:4300\u201317.","journal-title":"J Comp Neurol"},{"key":"1920_CR81","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.mri.2024.03.030","volume":"109","author":"K Sakaie","year":"2024","unstructured":"Sakaie K, Koenig K, Lerner A, Appleby B, Ogrocki P, Pillai JA, et al. Multi-shell diffusion MRI of the fornix as a biomarker for cognition in Alzheimer\u2019s disease. Magn Reson Imaging. 2024;109:221\u20136.","journal-title":"Magn Reson Imaging"},{"key":"1920_CR82","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","volume":"19","author":"W Jagust","year":"2018","unstructured":"Jagust W. Imaging the evolution and pathophysiology of Alzheimer disease. Nat Rev Neurosci. 2018;19:687\u2013700.","journal-title":"Nat Rev Neurosci"},{"key":"1920_CR83","doi-asserted-by":"publisher","first-page":"13953","DOI":"10.1038\/s41598-023-40092-x","volume":"13","author":"JN Adams","year":"2023","unstructured":"Adams JN, Chappel-Farley MG, Yaros JL, Taylor L, Harris AL, Mikhail A, et al. Functional network structure supports resilience to memory deficits in cognitively normal older adults with amyloid-\u03b2 pathology. Sci Rep. 2023;13:13953.","journal-title":"Sci Rep"},{"key":"1920_CR84","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biopsych.2018.10.018","volume":"86","author":"A Pignataro","year":"2019","unstructured":"Pignataro A, Meli G, Pagano R, Fontebasso V, Battistella R, Conforto G, et al. Activity-induced amyloid-\u03b2 oligomers drive compensatory synaptic rearrangements in brain circuits controlling memory of presymptomatic Alzheimer\u2019s disease mice. Biol Psychiatry. 2019;86:185\u201395.","journal-title":"Biol Psychiatry"},{"key":"1920_CR85","doi-asserted-by":"publisher","first-page":"9815","DOI":"10.1038\/s41467-024-53360-9","volume":"15","author":"N Vockert","year":"2024","unstructured":"Vockert N, Machts J, Kleineidam L, Nemali A, Incesoy EI, Bernal J, et al. Cognitive reserve against Alzheimer\u2019s pathology is linked to brain activity during memory formation. Nat Commun. 2024;15:9815.","journal-title":"Nat Commun"},{"key":"1920_CR86","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.tics.2021.05.008","volume":"25","author":"ML Elliott","year":"2021","unstructured":"Elliott ML, Knodt AR, Hariri AR. Striving toward translation: strategies for reliable fMRI measurement. Trends Cogn Sci. 2021;25:776\u201387.","journal-title":"Trends Cogn Sci"},{"key":"1920_CR87","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.nicl.2018.03.013","volume":"18","author":"C Hohenfeld","year":"2018","unstructured":"Hohenfeld C, Werner CJ, Reetz K. Resting-state connectivity in neurodegenerative disorders: is there potential for an imaging biomarker? Neuroimage Clin. 2018;18:849\u201370.","journal-title":"Neuroimage Clin"},{"key":"1920_CR88","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/ana.26168","volume":"90","author":"S Dautricourt","year":"2021","unstructured":"Dautricourt S, de Flores R, Landeau B, Poisnel G, Vanhoutte M, Delcroix N, et al. Longitudinal changes in hippocampal network connectivity in Alzheimer\u2019s disease. Ann Neurol. 2021;90:391\u2013406.","journal-title":"Ann Neurol"},{"key":"1920_CR89","doi-asserted-by":"publisher","first-page":"22682","DOI":"10.1073\/pnas.1012651108","volume":"107","author":"L Nyberg","year":"2010","unstructured":"Nyberg L, Salami A, Andersson M, Eriksson J, Kalpouzos G, Kauppi K, et al. Longitudinal evidence for diminished frontal cortex function in aging. Proc Natl Acad Sci U S A. 2010;107:22682\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1920_CR90","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1352458515619781","volume":"22","author":"C Enzinger","year":"2016","unstructured":"Enzinger C, Pinter D, Rocca MA, De Luca J, Sastre-Garriga J, Audoin B, et al. Longitudinal fMRI studies: exploring brain plasticity and repair in MS. Mult Scler. 2016;22:269\u201378.","journal-title":"Mult Scler"},{"key":"1920_CR91","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 2010;9:119\u201328.","journal-title":"Lancet Neurol"},{"key":"1920_CR92","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135.","journal-title":"Science"},{"key":"1920_CR93","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainresbull.2022.10.006","volume":"190","author":"DR Thal","year":"2022","unstructured":"Thal DR, Tom\u00e9 SO. The central role of tau in Alzheimer\u2019s disease: from neurofibrillary tangle maturation to the induction of cell death. Brain Res Bull. 2022;190:204\u201317.","journal-title":"Brain Res Bull"},{"key":"1920_CR94","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/brain\/awv338","volume":"139","author":"DT Jones","year":"2016","unstructured":"Jones DT, Knopman DS, Gunter JL, Graff-Radford J, Vemuri P, Boeve BF, et al. Cascading network failure across the Alzheimer\u2019s disease spectrum. Brain. 2016;139:547\u201362.","journal-title":"Brain"},{"key":"1920_CR95","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cortex.2017.09.018","volume":"97","author":"DT Jones","year":"2017","unstructured":"Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, et al. Tau, amyloid, and cascading network failure across the Alzheimer\u2019s disease spectrum. Cortex. 2017;97:143\u201359.","journal-title":"Cortex"},{"key":"1920_CR96","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc0655","volume":"13","author":"JS Sanchez","year":"2021","unstructured":"Sanchez JS, Becker JA, Jacobs HIL, Hanseeuw BJ, Jiang S, Schultz AP, et al. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer\u2019s disease assessed with positron emission tomography. Sci Transl Med. 2021;13:eabc0655.","journal-title":"Sci Transl Med"},{"key":"1920_CR97","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac193","volume":"4","author":"M Bilgel","year":"2022","unstructured":"Bilgel M, Wong DF, Moghekar AR, Ferrucci L, Resnick SM, Alzheimer\u2019s Disease Neuroimaging Initiative. Causal links among amyloid, tau, and neurodegeneration. Brain Commun. 2022;4:fcac193.","journal-title":"Brain Commun"},{"key":"1920_CR98","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad192","volume":"5","author":"E Mak","year":"2023","unstructured":"Mak E, Zhang L, Tan CH, Reilhac A, Shim HY, Wen MOQ, et al. Longitudinal associations between \u03b2-amyloid and cortical thickness in mild cognitive impairment. Brain Commun. 2023;5:fcad192.","journal-title":"Brain Commun"},{"key":"1920_CR99","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41593-018-0070-z","volume":"21","author":"HIL Jacobs","year":"2018","unstructured":"Jacobs HIL, Hedden T, Schultz AP, Sepulcre J, Perea RD, Amariglio RE, et al. Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nat Neurosci. 2018;21:424\u201331.","journal-title":"Nat Neurosci"},{"key":"1920_CR100","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neurobiolaging.2016.03.016","volume":"42","author":"A Rieckmann","year":"2016","unstructured":"Rieckmann A, Van Dijk KR, Sperling RA, Johnson KA, Buckner RL, Hedden T. Accelerated decline in white matter integrity in clinically normal individuals at risk for Alzheimer\u2019s disease. Neurobiol Aging. 2016;42:177\u201388.","journal-title":"Neurobiol Aging"},{"key":"1920_CR101","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ana.25406","volume":"85","author":"TM Harrison","year":"2019","unstructured":"Harrison TM, La Joie R, Maass A, Baker SL, Swinnerton K, Fenton L, et al. Longitudinal tau accumulation and atrophy in aging and alzheimer disease. Ann Neurol. 2019;85:229\u201340.","journal-title":"Ann Neurol"},{"key":"1920_CR102","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00259-023-06196-2","volume":"50","author":"D Visser","year":"2023","unstructured":"Visser D, Verfaillie SCJ, Bosch I, Brouwer I, Tuncel H, Coomans EM, et al. Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study. Eur J Nucl Med Mol Imaging. 2023;50:2409\u201319.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1920_CR103","doi-asserted-by":"crossref","unstructured":"Lattmann-Grefe R, Vockert N, Machts J, Suksangkharn Y, Yakupov R, Sch\u00fctze H, et al. Dysfunction of the episodic memory network in the Alzheimer\u2019s disease cascade. bioRxiv. 2024;620237.","DOI":"10.1101\/2024.10.25.620237"},{"key":"1920_CR104","first-page":"245","volume":"10","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, McCullough A, Mishra S, Blazey TM, Su Y, Christensen J, et al. Cross\u2010sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid \u03b2 positron emission tomography pathology. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2018;10:245\u201352.","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"1920_CR105","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/ADR-190121","volume":"3","author":"L Pasquini","year":"2019","unstructured":"Pasquini L, Rahmani F, Maleki-Balajoo S, La Joie R, Zarei M, Sorg C, et al. Medial temporal lobe disconnection and hyperexcitability across Alzheimer\u2019s disease stages. Journal of Alzheimer\u2019s Disease Reports. 2019;3:103\u201312.","journal-title":"Journal of Alzheimer's Disease Reports"},{"key":"1920_CR106","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamaneurol.2018.2505","volume":"76","author":"GS Gibbons","year":"2019","unstructured":"Gibbons GS, Lee VMY, Trojanowski JQ. Mechanisms of cell-to-cell transmission of pathological tau: a review: a review. JAMA Neurol. 2019;76:101\u20138.","journal-title":"JAMA Neurol"},{"key":"1920_CR107","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf099","volume":"7","author":"C Tremblay","year":"2025","unstructured":"Tremblay C, Rahayel S, Pastor-Bernier A, St-Onge F, Vo A, Rheault F, et al. Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer\u2019s disease. Brain Commun. 2025;7:099.","journal-title":"Brain Commun"},{"key":"1920_CR108","doi-asserted-by":"publisher","first-page":"e22978","DOI":"10.7554\/eLife.22978","volume":"6","author":"SL Leal","year":"2017","unstructured":"Leal SL, Landau SM, Bell RK, Jagust WJ. Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline. Elife. 2017;6:e22978.","journal-title":"Elife"},{"key":"1920_CR109","doi-asserted-by":"publisher","first-page":"e1408242024","DOI":"10.1523\/JNEUROSCI.1408-24.2024","volume":"6","author":"L Fischer","year":"2025","unstructured":"Fischer L, Molloy EN, Pichet BA, Vockert N, Marquardt J, Pacha PA, et al. Precuneus activity during retrieval is positively associated with amyloid burden in cognitively normal older APOE4 carriers. J Neurosci. 2025;6:e1408242024.","journal-title":"J Neurosci"},{"key":"1920_CR110","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac282","volume":"4","author":"G Moffat","year":"2022","unstructured":"Moffat G, Zhukovsky P, Coughlan G, Voineskos AN. Unravelling the relationship between amyloid accumulation and brain network function in normal aging and very mild cognitive decline: a longitudinal analysis. Brain Commun. 2022;4:fcac282.","journal-title":"Brain Commun"},{"key":"1920_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-01150-x","volume":"8","author":"S Palmqvist","year":"2017","unstructured":"Palmqvist S, Sch\u00f6ll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, et al. Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun. 2017;8:1\u201313.","journal-title":"Nat Commun"},{"key":"1920_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.70083","volume":"45","author":"J Ziontz","year":"2024","unstructured":"Ziontz J, Harrison TM, Fonseca C, Giorgio J, Han F, Lee J, et al. Connectivity, pathology, and ApoE4 interactions predict longitudinal tau spatial progression and memory. Hum Brain Mapp. 2024;45:e70083.","journal-title":"Hum Brain Mapp"},{"key":"1920_CR113","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.neuron.2023.11.014","volume":"112","author":"J Giorgio","year":"2024","unstructured":"Giorgio J, Adams JN, Maass A, Jagust WJ, Breakspear M. Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation. Neuron. 2024;112:676-86.e4.","journal-title":"Neuron"},{"key":"1920_CR114","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3233\/JAD-210673","volume":"85","author":"A Salami","year":"2022","unstructured":"Salami A, Adolfsson R, Andersson M, Blennow K, Lundquist A, Adolfsson AN, et al. Association of APOE \u025b4 and plasma p-tau181 with preclinical Alzheimer\u2019s disease and longitudinal change in hippocampus function. J Alzheimers Dis. 2022;85:1309\u201320.","journal-title":"J Alzheimers Dis"},{"key":"1920_CR115","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","volume":"73","author":"A de Calignon","year":"2012","unstructured":"de Calignon A, Polydoro M, Su\u00e1rez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, et al. Propagation of tau pathology in a model of early Alzheimer\u2019s disease. Neuron. 2012;73:685\u201397.","journal-title":"Neuron"},{"key":"1920_CR116","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41467-019-14159-1","volume":"11","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier N, Neitzel J, Rubinski A, Smith R, Strandberg O, Ossenkoppele R, et al. Functional brain architecture is associated with the rate of tau accumulation in Alzheimer\u2019s disease. Nat Commun. 2020;11:347.","journal-title":"Nat Commun"},{"key":"1920_CR117","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12:723\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"1920_CR118","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","volume":"80","author":"C Iadecola","year":"2013","unstructured":"Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80:844\u201366.","journal-title":"Neuron"},{"key":"1920_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11934","volume":"7","author":"Y Iturria-Medina","year":"2016","unstructured":"Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-P\u00e9rez JM, Evans AC. Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun. 2016;7:1\u201314.","journal-title":"Nat Commun"},{"key":"1920_CR120","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1100\/tsw.2009.72","volume":"9","author":"DR Thal","year":"2009","unstructured":"Thal DR. The precapillary segment of the blood-brain barrier and its relation to perivascular drainage in Alzheimer\u2019s disease and small vessel disease. Sci World J. 2009;9:557.","journal-title":"Sci World J"},{"key":"1920_CR121","doi-asserted-by":"publisher","first-page":"1412735","DOI":"10.3389\/fnagi.2024.1412735","volume":"16","author":"TR Li","year":"2024","unstructured":"Li TR, Li BL, Xu XR, Zhong J, Wang TS, Liu FQ, et al. Association of white matter hyperintensities with cognitive decline and neurodegeneration. Front Aging Neurosci. 2024;16:1412735.","journal-title":"Front Aging Neurosci"},{"key":"1920_CR122","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1212\/WNL.0000000000207378","volume":"101","author":"J Luo","year":"2023","unstructured":"Luo J, Ma Y, Agboola FJ, Grant E, Morris JC, McDade E, et al. Longitudinal relationships of white matter hyperintensities and Alzheimer disease biomarkers across the adult life span. Neurology. 2023;101:e164\u201377.","journal-title":"Neurology"},{"key":"1920_CR123","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/hipo.22690","volume":"27","author":"CM Fiford","year":"2017","unstructured":"Fiford CM, Manning EN, Bartlett JW, Cash DM, Malone IB, Ridgway GR, et al. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy. Hippocampus. 2017;27:249\u201362.","journal-title":"Hippocampus"},{"key":"1920_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-024-01606-5","volume":"16","author":"J Bernal","year":"2024","unstructured":"Bernal J, Menze I, Yakupov R, Peters O, Hellmann-Regen J, Freiesleben SD, et al. Longitudinal evidence for a mutually reinforcing relationship between white matter hyperintensities and cortical thickness in cognitively unimpaired older adults. Alzheimers Res Ther. 2024;16:1\u201314.","journal-title":"Alzheimers Res Ther"},{"key":"1920_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091479","volume":"10","author":"E Tamagno","year":"2021","unstructured":"Tamagno E, Guglielmotto M, Vasciaveo V, Tabaton M. Oxidative stress and beta amyloid in Alzheimer\u2019s disease. Which comes first: the chicken or the egg? Antioxidants. 2021;10:1479.","journal-title":"Antioxidants"},{"key":"1920_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-024-01417-8","volume":"16","author":"W-J Cha","year":"2024","unstructured":"Cha W-J, Yi D, Ahn H, Byun MS, Chang YY, Choi J-M, et al. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities. Alzheimers Res Ther. 2024;16:1\u20139.","journal-title":"Alzheimers Res Ther"},{"key":"1920_CR127","doi-asserted-by":"publisher","first-page":"116944","DOI":"10.1016\/j.neuroimage.2020.116944","volume":"218","author":"A Moscoso","year":"2020","unstructured":"Moscoso A, Rey-Bretal D, Silva-Rodr\u00edguez J, Aldrey JM, Cort\u00e9s J, P\u00edas-Peleteiro J, et al. White matter hyperintensities are associated with subthreshold amyloid accumulation. Neuroimage. 2020;218:116944.","journal-title":"Neuroimage"},{"key":"1920_CR128","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neurobiolaging.2022.01.006","volume":"112","author":"Y Li","year":"2022","unstructured":"Li Y, Kalpouzos G, Laukka EJ, Dekhtyar S, B\u00e4ckman L, Fratiglioni L, et al. Progression of neuroimaging markers of cerebral small vessel disease in older adults: a 6-year follow-up study. Neurobiol Aging. 2022;112:204\u201311.","journal-title":"Neurobiol Aging"},{"key":"1920_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01603-8","volume":"16","author":"I Menze","year":"2024","unstructured":"Menze I, Bernal J, Kaya P, Aki \u00c7, Pfister M, Geisend\u00f6rfer J, et al. Perivascular space enlargement accelerates in ageing and Alzheimer\u2019s disease pathology: evidence from a three-year longitudinal multicentre study. Alzheimers Res Ther. 2024;16:242.","journal-title":"Alzheimers Res Ther"},{"key":"1920_CR130","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/brain\/awv288","volume":"138","author":"Z Fan","year":"2015","unstructured":"Fan Z, Okello AA, Brooks DJ, Edison P. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer\u2019s disease. Brain. 2015;138:3685\u201398.","journal-title":"Brain"},{"key":"1920_CR131","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/npp.2012.255","volume":"38","author":"P Edison","year":"2013","unstructured":"Edison P, Ahmed I, Fan Z, Hinz R, Gelosa G, Ray Chaudhuri K, et al. Microglia, amyloid, and glucose metabolism in Parkinson\u2019s disease with and without dementia. Neuropsychopharmacology. 2013;38:938\u201349.","journal-title":"Neuropsychopharmacology"},{"key":"1920_CR132","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1042\/AN20120066","volume":"5","author":"V Sanchez-Guajardo","year":"2013","unstructured":"Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M. Neuroimmunological processes in Parkinson\u2019s disease and their relation to \u03b1-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro. 2013;5:113\u201339.","journal-title":"ASN Neuro"},{"key":"1920_CR133","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/693851","volume":"2014","author":"MW Marlatt","year":"2014","unstructured":"Marlatt MW, Bauer J, Aronica E, van Haastert ES, Hoozemans JJM, Joels M, et al. Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition. Neural Plast. 2014;2014:693851.","journal-title":"Neural Plast"},{"key":"1920_CR134","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2024","unstructured":"Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, et al. Neuroinflammation in Alzheimer disease. Nat Rev Immunol. 2024;25:321\u201352. https:\/\/doi.org\/10.1038\/s41577-024-01104-7.","journal-title":"Nat Rev Immunol"},{"key":"1920_CR135","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12974-020-01820-6","volume":"17","author":"R Ismail","year":"2020","unstructured":"Ismail R, Parbo P, Madsen LS, Hansen AK, Hansen KV, Schaldemose JL, et al. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer\u2019s disease: a longitudinal PET study. J Neuroinflammation. 2020;17:151.","journal-title":"J Neuroinflammation"},{"key":"1920_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2019.01.002","volume":"50","author":"S Bradburn","year":"2019","unstructured":"Bradburn S, Murgatroyd C, Ray N. Neuroinflammation in mild cognitive impairment and Alzheimer\u2019s disease: a meta-analysis. Ageing Res Rev. 2019;50:1\u20138.","journal-title":"Ageing Res Rev"},{"key":"1920_CR137","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1038\/s41380-023-02188-8","volume":"28","author":"A Finze","year":"2023","unstructured":"Finze A, Biechele G, Rauchmann B-S, Franzmeier N, Palleis C, Katzdobler S, et al. Individual regional associations between A\u03b2-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. Mol Psychiatry. 2023;28:4438\u201350.","journal-title":"Mol Psychiatry"},{"key":"1920_CR138","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/brain\/awae234","volume":"148","author":"J Appleton","year":"2025","unstructured":"Appleton J, Finn Q, Zanotti-Fregonara P, Yu M, Faridar A, Nakawah MO, et al. Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer\u2019s disease. Brain. 2025;148:119\u201332.","journal-title":"Brain"},{"key":"1920_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13699","volume":"20","author":"SM Rossano","year":"2024","unstructured":"Rossano SM, Johnson AS, Smith A, Ziaggi G, Roetman A, Guzman D, et al. Microglia measured by TSPO PET are associated with Alzheimer\u2019s disease pathology and mediate key steps in a disease progression model. Alzheimers Dement. 2024;20:2397.","journal-title":"Alzheimers Dement"},{"key":"1920_CR140","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.09.019","volume":"85","author":"J Zou","year":"2020","unstructured":"Zou J, Tao S, Johnson A, Tomljanovic Z, Polly K, Klein J, et al. Microglial activation, but not tau pathology, is independently associated with amyloid positivity and memory impairment. Neurobiol Aging. 2020;85:11\u201321.","journal-title":"Neurobiol Aging"},{"key":"1920_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-023-01209-6","volume":"15","author":"A Snellman","year":"2023","unstructured":"Snellman A, Ekblad LL, Tuisku J, Koivum\u00e4ki M, Ashton NJ, Lantero-Rodriguez J, et al. APOE \u03b54 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly. Alzheimers Res Ther. 2023;15:1\u201315.","journal-title":"Alzheimers Res Ther"},{"key":"1920_CR142","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2016.04.011","volume":"44","author":"WC Kreisl","year":"2016","unstructured":"Kreisl WC, Lyoo CH, Liow J-S, Wei M, Snow J, Page E, et al. (11)C-PBR28 binding to translocator protein increases with progression of Alzheimer\u2019s disease. Neurobiol Aging. 2016;44:53\u201361.","journal-title":"Neurobiol Aging"},{"key":"1920_CR143","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.22248","volume":"69","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Pike KE, Ch\u00e9telat G, Ellis KA, Mulligan RS, Bourgeat P, et al. Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease. Ann Neurol. 2011;69:181\u201392.","journal-title":"Ann Neurol"},{"key":"1920_CR144","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/alz.13654","volume":"20","author":"CS Fonseca","year":"2024","unstructured":"Fonseca CS, Baker SL, Dobyns L, Janabi M, Jagust WJ, Harrison TM. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging. Alzheimer\u2019s & Dementia. 2024;20:2526\u201337.","journal-title":"Alzheimer's & Dementia"},{"key":"1920_CR145","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neurobiolaging.2024.10.004","volume":"145","author":"X Chen","year":"2025","unstructured":"Chen X, Juarez A, Mason S, Kobayashi S, Baker SL, Harrison TM, et al. Longitudinal relationships between A\u03b2 and tau to executive function and memory in cognitively normal older adults. Neurobiol Aging. 2025;145:32\u201341.","journal-title":"Neurobiol Aging"},{"key":"1920_CR146","doi-asserted-by":"publisher","first-page":"e1512","DOI":"10.1212\/WNL.0000000000200137","volume":"98","author":"ME Farrell","year":"2022","unstructured":"Farrell ME, Papp KV, Buckley RF, Jacobs HIL, Schultz AP, Properzi MJ, et al. Association of emerging \u03b2-amyloid and tau pathology with early cognitive changes in clinically normal older adults. Neurology. 2022;98:e1512\u201324.","journal-title":"Neurology"},{"key":"1920_CR147","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1002\/alz.14036","volume":"20","author":"ME Farrell","year":"2024","unstructured":"Farrell ME, Thibault EG, Alex Becker J, Price JC, Healy BC, Hanseeuw BJ, et al. Spatial extent as a sensitive amyloid-PET metric in preclinical Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia. 2024;20:5434\u201349.","journal-title":"Alzheimer's & Dementia"},{"key":"1920_CR148","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/alz.13355","volume":"20","author":"C Boccalini","year":"2024","unstructured":"Boccalini C, Ribaldi F, Hristovska I, Arnone A, Peretti DE, Mu L, et al. The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline. Alzheimer\u2019s & Dementia. 2024;20:221\u201333.","journal-title":"Alzheimer's & Dementia"},{"key":"1920_CR149","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/brain\/awaa088","volume":"143","author":"M Malpetti","year":"2020","unstructured":"Malpetti M, Kievit RA, Passamonti L, Jones PS, Tsvetanov KA, Rittman T, et al. Microglial activation and tau burden predict cognitive decline in Alzheimer\u2019s disease. Brain. 2020;143:1588\u2013602.","journal-title":"Brain"},{"key":"1920_CR150","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.nicl.2019.101771","volume":"22","author":"J Ottoy","year":"2019","unstructured":"Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, et al. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and F-FDG-PET imaging. Neuroimage Clin. 2019;22:101771.","journal-title":"Neuroimage Clin"},{"key":"1920_CR151","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neurobiolaging.2024.04.005","volume":"142","author":"M Hou","year":"2024","unstructured":"Hou M, Bergamino M, de Chastelaine M, Sambamoorthy S, Rugg MD. Free water-corrected fractional anisotropy of the fornix and parahippocampal cingulum predicts longitudinal memory change in cognitively healthy older adults. Neurobiol Aging. 2024;142:17\u201326.","journal-title":"Neurobiol Aging"},{"key":"1920_CR152","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neurobiolaging.2018.02.021","volume":"68","author":"Z Song","year":"2018","unstructured":"Song Z, Farrell ME, Chen X, Park DC. Longitudinal accrual of neocortical amyloid burden is associated with microstructural changes of the fornix in cognitively normal adults. Neurobiol Aging. 2018;68:114\u201322.","journal-title":"Neurobiol Aging"},{"key":"1920_CR153","doi-asserted-by":"publisher","first-page":"46263","DOI":"10.1038\/srep46263","volume":"7","author":"D Ferreira","year":"2017","unstructured":"Ferreira D, Verhagen C, Hern\u00e1ndez-Cabrera JA, Cavallin L, Guo C-J, Ekman U, et al. Distinct subtypes of Alzheimer\u2019s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications. Sci Rep. 2017;7:46263.","journal-title":"Sci Rep"},{"key":"1920_CR154","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neurobiolaging.2016.12.002","volume":"51","author":"T Gorbach","year":"2017","unstructured":"Gorbach T, Pudas S, Lundquist A, Or\u00e4dd G, Josefsson M, Salami A, et al. Longitudinal association between hippocampus atrophy and episodic-memory decline. Neurobiol Aging. 2017;51:167\u201376.","journal-title":"Neurobiol Aging"},{"key":"1920_CR155","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.2967\/jnumed.112.116137","volume":"54","author":"S Shokouhi","year":"2013","unstructured":"Shokouhi S, Claassen D, Kang H, Ding Z, Rogers B, Mishra A, et al. Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET. J Nucl Med. 2013;54:1564\u20139.","journal-title":"J Nucl Med"},{"key":"1920_CR156","doi-asserted-by":"publisher","first-page":"102725","DOI":"10.1016\/j.nicl.2021.102725","volume":"31","author":"C Groot","year":"2021","unstructured":"Groot C, Risacher SL, Chen JQA, Dicks E, Saykin AJ, Cl MD, et al. Differential trajectories of hypometabolism across cognitively-defined Alzheimer\u2019s disease subgroups. Neuroimage Clin. 2021;31:102725.","journal-title":"Neuroimage Clin"},{"key":"1920_CR157","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1002\/hbm.24613","volume":"40","author":"AM Staffaroni","year":"2019","unstructured":"Staffaroni AM, Cobigo Y, Elahi FM, Casaletto KB, Walters SM, Wolf A, et al. A longitudinal characterization of perfusion in the aging brain and associations with cognition and neural structure. Hum Brain Mapp. 2019;40:3522\u201333.","journal-title":"Hum Brain Mapp"},{"key":"1920_CR158","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1212\/WNL.0b013e3181e3966e","volume":"74","author":"JL O\u2019Brien","year":"2010","unstructured":"O\u2019Brien JL, O\u2019Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, et al. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology. 2010;74:1969\u201376.","journal-title":"Neurology"},{"key":"1920_CR159","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/brain\/awv007","volume":"138","author":"W Huijbers","year":"2015","unstructured":"Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, et al. Amyloid-\u03b2 deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain. 2015;138:1023\u201335.","journal-title":"Brain"},{"key":"1920_CR160","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1523\/JNEUROSCI.3067-17.2018","volume":"38","author":"AM Staffaroni","year":"2018","unstructured":"Staffaroni AM, Brown JA, Casaletto KB, Elahi FM, Deng J, Neuhaus J, et al. The longitudinal trajectory of default mode network connectivity in healthy older adults varies as a function of age and is associated with changes in episodic memory and processing speed. J Neurosci. 2018;38:2809\u201317.","journal-title":"J Neurosci"},{"key":"1920_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-025-01742-6","volume":"17","author":"L Fischer","year":"2025","unstructured":"Fischer L, Adams JN, Molloy EN, Vockert N, Tremblay-Mercier J, Remz J, et al. Differential effects of aging, Alzheimer\u2019s pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults. Alzheimers Res Ther. 2025;17:1\u201320.","journal-title":"Alzheimers Res Ther"},{"key":"1920_CR162","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci9070170","volume":"9","author":"OM Al-Janabi","year":"2019","unstructured":"Al-Janabi OM, Bauer CE, Goldstein LB, Murphy RR, Bahrani AA, Smith CD, et al. White matter hyperintensity regression: comparison of brain atrophy and cognitive profiles with progression and stable groups. Brain Sci. 2019;9:170.","journal-title":"Brain Sci"},{"key":"1920_CR163","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference. Nat Commun. 2018;9:4273.","journal-title":"Nat Commun"},{"key":"1920_CR164","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41583-023-00779-6","volume":"25","author":"AL Young","year":"2024","unstructured":"Young AL, Oxtoby NP, Garbarino S, Fox NC, Barkhof F, Schott JM, et al. Data-driven modelling of neurodegenerative disease progression: thinking outside the black box. Nat Rev Neurosci. 2024;25:111\u201330.","journal-title":"Nat Rev Neurosci"},{"key":"1920_CR165","doi-asserted-by":"publisher","first-page":"6750","DOI":"10.1038\/s41467-023-42305-3","volume":"14","author":"R Smith","year":"2023","unstructured":"Smith R, Capotosti F, Schain M, Ohlsson T, Vokali E, Molette J, et al. The \u03b1-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases. Nat Commun. 2023;14:6750.","journal-title":"Nat Commun"},{"key":"1920_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-025-00822-3","volume":"20","author":"N Franzmeier","year":"2025","unstructured":"Franzmeier N, Roemer-Cassiano SN, Bernhardt AM, Dehsarvi A, Dewenter A, Steward A, et al. Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer\u2019s disease. Mol Neurodegener. 2025;20:1\u201315.","journal-title":"Mol Neurodegener"},{"key":"1920_CR167","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41380-023-01950-2","volume":"28","author":"TJ Betthauser","year":"2023","unstructured":"Betthauser TJ. In vitro evidence for a nonselective 4R tau PET tracer. Mol Psychiatry. 2023;28:1398\u20139.","journal-title":"Mol Psychiatry"},{"key":"1920_CR168","doi-asserted-by":"publisher","first-page":"1380561","DOI":"10.3389\/fnagi.2024.1380561","volume":"16","author":"MS Bavarsad","year":"2024","unstructured":"Bavarsad MS, Grinberg LT. SV2A PET imaging in human neurodegenerative diseases. Front Aging Neurosci. 2024;16:1380561.","journal-title":"Front Aging Neurosci"},{"key":"1920_CR169","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neulet.2018.07.038","volume":"691","author":"Z Cai","year":"2019","unstructured":"Cai Z, Li S, Matuskey D, Nabulsi N, Huang Y. PET imaging of synaptic density: a new tool for investigation of neuropsychiatric diseases. Neurosci Lett. 2019;691:44\u201350.","journal-title":"Neurosci Lett"},{"key":"1920_CR170","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jacc.2019.10.062","volume":"75","author":"M Cortes-Canteli","year":"2020","unstructured":"Cortes-Canteli M, Iadecola C. Alzheimer\u2019s disease and vascular aging: JACC focus seminar. J Am Coll Cardiol. 2020;75:942\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"1920_CR171","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00401-021-02393-1","volume":"143","author":"V Perosa","year":"2022","unstructured":"Perosa V, Oltmer J, Munting LP, Freeze WM, Auger CA, Scherlek AA, et al. Perivascular space dilation is associated with vascular amyloid-\u03b2 accumulation in the overlying cortex. Acta Neuropathol. 2022;143:331\u201348.","journal-title":"Acta Neuropathol"},{"key":"1920_CR172","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00234-020-02562-1","volume":"63","author":"LL de Godoy","year":"2021","unstructured":"de Godoy LL, Alves CAPF, Saavedra JSM, Studart-Neto A, Nitrini R, da Costa Leite C, et al. Understanding brain resilience in superagers: a systematic review. Neuroradiology. 2021;63:663\u201383.","journal-title":"Neuroradiology"},{"key":"1920_CR173","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1093\/brain\/awad100","volume":"146","author":"DI Bocancea","year":"2023","unstructured":"Bocancea DI, Svenningsson AL, van Loenhoud AC, Groot C, Barkhof F, Strandberg O, et al. Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis. Brain. 2023;146:3719\u201334.","journal-title":"Brain"},{"key":"1920_CR174","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1002\/alz.12899","volume":"19","author":"M Zhang","year":"2023","unstructured":"Zhang M, Ganz AB, Rohde S, Rozemuller AJM, Bank NB, Reinders MJT, et al. Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: an age-continuous perspective. Alzheimers Dement. 2023;19:2831\u201341.","journal-title":"Alzheimers Dement"},{"key":"1920_CR175","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/alz.12797","volume":"19","author":"MW Weiner","year":"2023","unstructured":"Weiner MW, Veitch DP, Miller MJ, Aisen PS, Albala B, Beckett LA, et al. Increasing participant diversity in AD research: plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer\u2019s Disease Neuroimaging Initiative 4. Alzheimers Dement. 2023;19:307\u201317.","journal-title":"Alzheimers Dement"},{"key":"1920_CR176","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ana.25948","volume":"89","author":"KL Meeker","year":"2021","unstructured":"Meeker KL, Wisch JK, Hudson D, Coble D, Xiong C, Babulal GM, et al. Socioeconomic status mediates racial differences seen using the AT(N) framework. Ann Neurol. 2021;89:254\u201365.","journal-title":"Ann Neurol"},{"key":"1920_CR177","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/ana.26847","volume":"95","author":"C Lachner","year":"2024","unstructured":"Lachner C, Craver EC, Babulal GM, Lucas JA, Ferman TJ, White RO, et al. Disparate dementia risk factors are associated with cognitive impairment and rates of decline in African Americans. Ann Neurol. 2024;95:518\u201329.","journal-title":"Ann Neurol"},{"key":"1920_CR178","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.1002\/alz.13844","volume":"20","author":"EM Arenaza-Urquijo","year":"2024","unstructured":"Arenaza-Urquijo EM, Boyle R, Casaletto K, Anstey KJ, Vila-Castelar C, Colverson A, et al. Sex and gender differences in cognitive resilience to aging and Alzheimer\u2019s disease. Alzheimers Dement. 2024;20:5695\u2013719.","journal-title":"Alzheimers Dement"},{"key":"1920_CR179","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404:572\u2013628.","journal-title":"Lancet"},{"key":"1920_CR180","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","volume":"38","author":"J Cummings","year":"2024","unstructured":"Cummings J, Osse AML, Cammann D, Powell J, Chen J. Anti-amyloid monoclonal antibodies for the treatment of Alzheimer\u2019s disease. BioDrugs. 2024;38:5\u201322.","journal-title":"BioDrugs"},{"key":"1920_CR181","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol. 2017;134:187\u2013205.","journal-title":"Acta Neuropathol"},{"key":"1920_CR182","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1093\/brain\/awad059","volume":"146","author":"JL Robinson","year":"2023","unstructured":"Robinson JL, Xie SX, Baer DR, Suh E, Van Deerlin VM, Loh NJ, et al. Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated. Brain. 2023;146:2557\u201369.","journal-title":"Brain"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01920-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01920-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01920-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:59:24Z","timestamp":1781621964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-025-01920-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":182,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1920"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01920-6","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}